연구성과로 돌아가기

2021 연구성과별 연구자 정보 (209 / 2991)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
ARO-HSD, AN INVESTIGATIONAL RNAi THERAPEUTIC, DEMONSTRATES REDUCTION IN ALT AND HEPATIC HSD17B13 mRNA AND PROTEIN IN PATIENTS WITH NASH OR SUSPECTED NASH Yuen, Man Fung Yuen, MF 2 Univ Hong Kong, Queen Mary Hosp, Hong Kong, Peoples R China C-4466-2009 Yuen, Richard Man Fung
ARO-HSD, AN INVESTIGATIONAL RNAi THERAPEUTIC, DEMONSTRATES REDUCTION IN ALT AND HEPATIC HSD17B13 mRNA AND PROTEIN IN PATIENTS WITH NASH OR SUSPECTED NASH Schwabe, Christian Schwabe, C 3 New Zealand Clin Res, Auckland, New Zealand
ARO-HSD, AN INVESTIGATIONAL RNAi THERAPEUTIC, DEMONSTRATES REDUCTION IN ALT AND HEPATIC HSD17B13 mRNA AND PROTEIN IN PATIENTS WITH NASH OR SUSPECTED NASH Yoon, Ki Tae Yoon, KT 4 Pusan Natl Univ, Yangsan Hosp, Busan, South Korea
ARO-HSD, AN INVESTIGATIONAL RNAi THERAPEUTIC, DEMONSTRATES REDUCTION IN ALT AND HEPATIC HSD17B13 mRNA AND PROTEIN IN PATIENTS WITH NASH OR SUSPECTED NASH Heo, Jeong Heo, J 5 Pusan Natl Univ, Busan, South Korea MHQ-1390-2025 Heo, Jeong
ARO-HSD, AN INVESTIGATIONAL RNAi THERAPEUTIC, DEMONSTRATES REDUCTION IN ALT AND HEPATIC HSD17B13 mRNA AND PROTEIN IN PATIENTS WITH NASH OR SUSPECTED NASH Heo, Jeong Heo, J 5 Med Res Inst, Busan, South Korea MHQ-1390-2025 Heo, Jeong
ARO-HSD, AN INVESTIGATIONAL RNAi THERAPEUTIC, DEMONSTRATES REDUCTION IN ALT AND HEPATIC HSD17B13 mRNA AND PROTEIN IN PATIENTS WITH NASH OR SUSPECTED NASH Scott, Russell Scott, R 6 Christchurch Hosp, Lipid & Diabet Res, Christchurch, New Zealand
ARO-HSD, AN INVESTIGATIONAL RNAi THERAPEUTIC, DEMONSTRATES REDUCTION IN ALT AND HEPATIC HSD17B13 mRNA AND PROTEIN IN PATIENTS WITH NASH OR SUSPECTED NASH Lee, Jeong-Hoon Lee, JH 7 Seoul Natl Univ Hosp, Seoul, South Korea
ARO-HSD, AN INVESTIGATIONAL RNAi THERAPEUTIC, DEMONSTRATES REDUCTION IN ALT AND HEPATIC HSD17B13 mRNA AND PROTEIN IN PATIENTS WITH NASH OR SUSPECTED NASH Lee, Jung Il Lee, JI 8 Gangnam Severance Hosp, Seoul, South Korea
ARO-HSD, AN INVESTIGATIONAL RNAi THERAPEUTIC, DEMONSTRATES REDUCTION IN ALT AND HEPATIC HSD17B13 mRNA AND PROTEIN IN PATIENTS WITH NASH OR SUSPECTED NASH Kweon, Young Oh Kweon, YO 9 Kyungpook Natl Univ, Daegu, South Korea
ARO-HSD, AN INVESTIGATIONAL RNAi THERAPEUTIC, DEMONSTRATES REDUCTION IN ALT AND HEPATIC HSD17B13 mRNA AND PROTEIN IN PATIENTS WITH NASH OR SUSPECTED NASH Weltman, Martin Weltman, M 10 Nepean Hosp, Kingswood, NSW, Australia
ARO-HSD, AN INVESTIGATIONAL RNAi THERAPEUTIC, DEMONSTRATES REDUCTION IN ALT AND HEPATIC HSD17B13 mRNA AND PROTEIN IN PATIENTS WITH NASH OR SUSPECTED NASH Harrison, Stephen A. Harrison, SA 11 Pinnacle Clin Res Ctr, San Antonio, TX USA GON-3283-2022 Harrison, Stephen
ARO-HSD, AN INVESTIGATIONAL RNAi THERAPEUTIC, DEMONSTRATES REDUCTION IN ALT AND HEPATIC HSD17B13 mRNA AND PROTEIN IN PATIENTS WITH NASH OR SUSPECTED NASH Neuschwander-Tetri, Brent A. Neuschwander-Tetri, BA 12 St Louis Univ, Sch Med, St Louis, MO 63103 USA IST-8116-2023 Neuschwander-Tetri, Brent
ARO-HSD, AN INVESTIGATIONAL RNAi THERAPEUTIC, DEMONSTRATES REDUCTION IN ALT AND HEPATIC HSD17B13 mRNA AND PROTEIN IN PATIENTS WITH NASH OR SUSPECTED NASH Cusi, Kenneth Cusi, K 13 Univ Florida, Gainesville, FL 32611 USA ADV-2401-2022 Cusi, Kenneth
ARO-HSD, AN INVESTIGATIONAL RNAi THERAPEUTIC, DEMONSTRATES REDUCTION IN ALT AND HEPATIC HSD17B13 mRNA AND PROTEIN IN PATIENTS WITH NASH OR SUSPECTED NASH Loomba, Rohit Loomba, R 14 UCSD, NAFLD Res Ctr, Div Gastroenterol, La Jolla, CA USA AAE-7831-2019 Loomba, Rohit
ARO-HSD, AN INVESTIGATIONAL RNAi THERAPEUTIC, DEMONSTRATES REDUCTION IN ALT AND HEPATIC HSD17B13 mRNA AND PROTEIN IN PATIENTS WITH NASH OR SUSPECTED NASH Garcia-Medel, Eric Garcia-Medel, E 15 Arrowhead Pharmaceut, Pasadena, CA USA
페이지 이동: